08:09 AM EDT, 07/02/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Tuesday that the US Food and Drug Administration has approved its abbreviated new drug application for its Naproxen delayed-release tablets, a generic version of EC-Naprosyn.

Naproxen is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation.

US annual sales for Naproxen delayed-release tablets total about $36.7 million, based on April 2024 moving annual total data.